Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania

Informa UK Limited - Tập 10 Số 1 - 2017
Margaret Ewen1, Warren Kaplan2, Teferi Gedif Fenta3, M Justin-Temu4, Catherine Vialle-Valentin5, Zafar Mirza6, B.J. Regeer7, Marjolein Zweekhorst7, Richard Laing8
1Health Action International (HAI), Overtoom 60/II, 1054HK, Amsterdam, Netherlands
2Boston University School of Public Health, Boston, MA, USA
3University of Addis Ababa, Addis Ababa, Ethiopia
4Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania
5Harvard Pilgrim Health Care Institute, Boston, MA, USA
6World Health Organization, Regional Office for the Eastern Mediterranean, Cairo, Egypt
7Athena Institute, VU University, Amsterdam, Netherlands
8University of Western Cape, Cape Town, South Africa

Tóm tắt

Từ khóa


Tài liệu tham khảo

World Health Organization. World Medicines Strategy 2004-2007. Geneva: World Health Organization; 2004.

World Health Organization/Health Action International. Measuring medicine prices, availability, affordability and price components. 2nd edition. Geneva, 2008. Available at http://haiweb.org/what-we-do/price-availability-affordability/collecting-evidence-on-medicine-prices-availability/ . Accessed 8 Nov 2015.

Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 2009;373:240-249.

Van Mourik MSM, Cameron A, Ewen M, Laing RO. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord. 2010;10:25.

Volman B. Direct costs and availability of diabetes medicines in low- and middle-income countries. WHO/HAI 2008. Available at http://apps.who.int/medicinedocs/en/d/Js18387en/ . Accessed 8 Nov 2015.

Cameron A, Bansal A, Dua T, Hill S, Moshe S, Mantel-Teeuwisse A, Saxena S. Mapping the availability, price and affordability of antiepileptic drugs in 46 countries. Epilepsia. 2012;53(6):962–69. doi: 10.1111/j.1528-1167.2012.03446.x .

Gelders S, Ewen M, Noguchi N, Laing R. Price, availability and affordability. An international comparison of chronic disease medicines.WHO EMRO/HAI 2006.Available at http://apps.who.int/medicinedocs/documents/s16180e/s16180e.pdf . Accessed 8 Nov 2015.

World Health Organization. Local production for access to medical products. Developing a framework to improve public health. Geneva: World Health Organization, Essential Medicines and Products: Policy brief; 2014.

Kaplan W. Local production and access to medicines in low- and middle-income countries. A literature review and critical analysis. Geneva: World Health Organization; 2013.

Kaplan WA, Ritz LS, Vitello M. Local production of medical technologies and its effect on access in low and middle income countries: a systematic review of the literature. South Med Rev. 2011;4(2):51–61.

World Health Organization. World Medicines Strategy 2008-2013. Geneva: World Health Organization; 2008.

World Health Organization. How to develop and implement a national drug policy. 2nd ed. Geneva: World Health Organization; 2001.

Berger M, Murugi J, Buch E et al. Strengthening pharmaceutical innovation in Africa. Council on Health Research for Development (COHRED), New Partnership for Africa’s Development (NEPAD) 2009. Available at http://policycures.org/downloads/COHRED-NEPAD_Strengthening_Pharmaceutical_Innovation_AfricaREPORT.pdf . Accessed 10 Sept 2016.

Mackintosh M, Banda G, Tibandebage P, Wamae W (Eds.).Making medicines in Africa. The political economy of industrializing for local health. International Political Economy Series, 2015. Available at http://www.palgrave.com/us/book/9781137546463 . Accessed 10 Sept 2016.

Lopes C. Making medicine in Africa - the untapped possibilities that could save millions of lives. 17 February 2015. Available at http://mgafrica.com/article/2015-02-17-manufacturing-pharmaceuticals-in-africa-the-untapped-opportunity-that-could-save-countless-lives . Accessed 8 Oct 2016.

Mackintosh M, Mujinja PG. Pricing and competition in essential medicines markets: the supply chain to Tanzania and the role of NGOs. IKD Working Paper No. 32. Open University Research Centre on Innovation Knowledge and Development. Available at http://www.open.ac.uk/ikd/sites/www.open.ac.uk.ikd/files/files/working-papers/ikd-working-paper-32.pdf . Accessed 8 Oct 2016.

Mujinja P, Mackintosh M, Justin-Temu M, Wuyts M. Local production of pharmaceuticals in Africa and access to essential medicines: ‘urban bias’ in access to imported medicines in Tanzania and its policy implications. Globalization and Health. 2014;10:12.

Israel C, Mackintosh M, Tibandebage P, Mhede E, Mujinja PGM. Improving the supply chain for the health sector: what role for local manufacturing? Policy research for development. Working paper 14/6. Available at http://www.repoa.or.tz/documents/REPOA_WP_14_6.pdf . Accessed 8 Oct 2016.

Kuanpoth J. Patents and access to antiretroviral medicines in Vietnam after World Trade Organization accession. J World Intell Prop. 2007;10:201–24.

Chowdury N, Kabir ER. Per pill price differences across therapeutic categories: a study of the essential drug brands marketed by multinational and local pharmaceutical companies in Bangladesh. African J Marketing Mgt. 2009;1:220–6.

Sweileh W, Jaradat N, Mustafa A. Antibiotic drug cost variations in Palestine: physicians and patients dilemma. An-Najah Univ J Res. 2004;18(1):73–9.

Shafie AA, Hassali MA. Price comparison between innovator and generic medicines sold by community pharmacies in the state of Penang, Malaysia. J Generic Med. 2008;6:35–42.

The World Bank. Procurement of goods, works, and non-consulting services under IBRD loans and IDA credits and grants by World Bank Borrowers. Washington: World Bank; 2011.

Global Fund to Fight AIDS, Tuberculosis and Malaria. Guide to Global Fund policies on procurement and supply management of health products. Geneva: Global Fund; 2012.

Gray AL. Medicine pricing interventions-the South African experience. Southern Med Review. 2009;2(2):15–9.

Ministry of Health and Ministry of Industry, Federal Democratic Republic of Ethiopia. National strategy and plan of action for pharmaceutical manufacturing development in Ethiopia (2015-2025). Developing the pharmaceutical industry and improving access. July 2015. Available at http://www.who.int/phi/publications/Ethiopia_strategy_local_poduction.pdf . Accessed 12 Nov 2015.

World Health Organization/Health Action International. Prices and availability of locally produced and imported medicines in Ethiopia. Available at  http://haiweb.org/what-we-do/price-availability-affordabilitymeasuring-the-availability-and-prices-of-locally-produced-and-imported-medicines/ . Accessed 5 Dec 2016.

World Health Organization/Health Action International. Prices and availability of locally produced and imported medicines in Tanzania. Available at  http://haiweb.org/what-we-do/price-availability-affordability/measuring-the-availability-and-prices-of-locally-produced-and-imported-medicines . Accessed 5 Dec 2016.